Back

Verona Pharma Plc

23/04/2023

Verona Pharma is a biopharmaceutical company based in the U.K. specializing in developing various therapies for treating respiratory diseases such as COPD, cystic fibrosis, and asthma. Verona is particularly interesting for investors since it is addressing some of the most acute orphan diseases, also called rare diseases.

Back

Related articles

Ypsomed Holding AG

05/07/2025

Ypsomed Holding AG is a Swiss med‑tech innovator focused on self‑injection and drug delivery systems, primarily serving diabetes and expanding into other therapeutic areas. Listed on SIX under YPSN, the...

Read More >>>

Siegfried Holding AG

05/07/2025

Siegfried Holding AG is a Swiss-based global leader in contract development and manufacturing (CDMO) for the pharmaceutical industry. Founded in 1873 and headquartered in Zofingen, Switzerland, Siegfried operates 13 facilities...

Read More >>>

Enjoy Thanksgivings

09/11/2023

We keep enjoying Thanksgiving and all other regular family meetings – this is perfectly right except that with each run, we put a little more weight on. But, thanks to...

Read More >>>

Mirum Pharmaceuticals Inc.

23/04/2023

Mirum Pharmaceuticals identifies, develops, and commercializes novel therapies for rare diseases. Their main product is Livmarli for the treatment of Alagille syndrome. On March 14 the FDA approved Livmarli for...

Read More >>>

Amgen

12/01/2023

AMGN is a slow growth company; 2023 sales should increase by just about 5%. Yet, expectations for the biotech’s landmark lung cancer drug, Lumakras, are high, i.e., it should become...

Read More >>>